Banks review fees

Bank Hapoalim, which recently raised some of their 250 fees, said the bank reviews the system and number of fees it charges its customers from time-to-time but that no decision has been made yet on whether any other changes would be made.

By SHARON WROBEL
December 20, 2006 07:02

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Banks are reviewing their fees list in an effort to find ways of reducing the number of charges after the Governor of the Bank of Israel, Stanley Fischer, rejected their request to act in order to help block legislation that would impose regulation on banking fees. Bank Hapoalim, which recently raised some of their 250 fees, said the bank reviews the system and number of fees it charges its customers from time-to-time but that no decision has been made yet on whether any other changes would be made.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS